About Walking Fish Therapeutics
Walking Fish Therapeutics is a company based in San Francisco (United States) founded in 2019 by Seenu Kothakota, Lewis T Williams, Mark Selby, and Tom Brennan. Walking Fish Therapeutics has raised $123 million across 2 funding rounds from investors including Northpond Ventures, First Spark Ventures and TMCP. Walking Fish Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter San Francisco, United States
- Founders Seenu Kothakota, Lewis T Williams, Mark Selby, Tom Brennan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Walking Fish Therapeutics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$123 M (USD)
in 2 rounds
-
Latest Funding Round
$73 M (USD), Series A
Feb 16, 2022
-
Investors
Northpond Ventures
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Walking Fish Therapeutics
Walking Fish Therapeutics has successfully raised a total of $123M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $73 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Walking Fish Therapeutics
Walking Fish Therapeutics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Northpond Ventures, First Spark Ventures and TMCP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life sciences & tech sectors
|
Locked | Locked | Locked | |
|
A venture capital fund focused on deep tech innovations is managed.
|
Locked | Locked | Locked | |
|
Private equity investments in China are managed by TMCP.
|
Locked | Locked | Locked |
Investor details for Walking Fish Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Walking Fish Therapeutics
Investment portfolio details for Walking Fish Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Walking Fish Therapeutics
Detailed financials for Walking Fish Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Walking Fish Therapeutics Comparisons
Peer comparison for Walking Fish Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Walking Fish Therapeutics
Walking Fish Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Walking Fish Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Walking Fish Therapeutics
Complete news archive for Walking Fish Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Walking Fish Therapeutics
Walking Fish Therapeutics was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Walking Fish Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Lewis T Williams is the current CEO of Walking Fish Therapeutics. They have also founded this company.
Walking Fish Therapeutics is a funded company, having raised a total of $123M across 2 funding rounds to date.
Walking Fish Therapeutics was founded in 2019 in San Francisco, United States, within the biotechnology sector. Cell-based solutions are developed to address cancer and immunological disorders. Proprietary technology based on B cells and their derivatives is used to generate therapeutic proteins, including antibodies for infectious diseases, replacement proteins for deficiencies, immune-inhibitory proteins for autoimmune conditions, and regenerative proteins. Antigens are supplied to support antitumor immune responses in oncology applications.
Walking Fish Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Walking Fish Therapeutics has 6 investors. Key investors include Northpond Ventures, First Spark Ventures, TMCP, Emerson Collective, and Illumina Ventures.